Prevention of disability in leprosy (Hansen's disease) Infections and Infestations
Conditions
Interventions
Prevention and reduction of disability by self-care in the community is facilitated using existing public health systems and Mitanins (front-line health worker) .The self-care intervention will be st
Sponsors
University of Birmingham
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All patients with neuropathy due to leprosy, at risk for developing ulcers (had an ulcer in the past) or currently have an ulcer will be included in the study.
Exclusion criteria
Exclusion criteria: Children less than 18 years old
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quantitative outcome 1. The prevalence of ulcers among those at risk of an ulcer is measured using case record form for clinical assessment at baseline , 3 months , 6 months and 12 months. 2. The total surface area of ulcers (cm2) among those with ulcers is measured using photographs at baseline, 3 months, 6 months and 12 months. 3. Disability severity level: Eye, Hand and Foot score (EHF score) is measured using case record form for clinical assessment at baseline, 3 months, 6 months and 12 months. Qualitative outcome 1. Fidelity: 1.1. Evaluation of Mitanin trainers' training measured using pre and post test questionnaire at on off training program for trainers 1.2. Evaluation of cascaded training of Mitanins by Mitanin trainers to measure delivery of training using observation checklist and knowledge gain using pre and post questionnaires. 2. Delivery of intervention 2.2. Home visit records (of over 4 week period prior to data extraction) measured at 4 weeks after Post intervention assessment at 3 months, 4 weeks after Post intervention assessment 2 at 6 months and 4 weeks before final intervention assessment at 12 months 2.3. Observation of home visits documented using checklist at least 12 weeks after cascaded training of Mitanins 2.4. Interview with mitanins documented using interview guide at least 12 weeks after cascaded training of Mitanins 3. Community member experience of intervention and impact 3.1. Interview with patients and family members using interview guide at least 12 weeks after cascaded training of Mitanins. 3.2. Interview with community representatives using interview guide at least 12 weeks after cascaded training of Mitanins. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Psychological Outcome 1.1. Quality of life is measured using EQ 5D 3L and EQ VAS (visual analogue scale) at Baseline, 6 months and 12 months 1.2. Subjective well being is measured using life satisfaction questionnaire at Baseline, 6 months and 12 months 2. Social outcomes using Participation scale at Baseline, 6 months and 12 months. | — |
Countries
India
Outcome results
None listed